The IFNL1 gene helps your body make interferon lambda 1, a signal used to defend surfaces like the airways and gut against viruses. This gene plays an important role in helping nearby cells switch on early antiviral defenses. If the gene does not work well, these barrier tissues may have a weaker first response to some infections, which can influence how the immune system handles illness. Most changes in the IFNL1 gene are small and do not cause a clear health problem on their own.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly help govern when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you react to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
IFNL1Gene function
What if the gene works
The IFNL1 gene helps the body fight viruses, especially at barrier surfaces such as the lungs and gut. Its protein signals nearby cells to switch on antiviral defenses and support a balanced immune response.
Risk
What if the gene does not work
Changes in the IFNL1 gene can range from milder to more severe variants. These changes may reduce interferon lambda 1 signaling, weakening how cells switch on antiviral defenses at body surfaces such as the airways and gut.
Treatment
What does that mean for your treatment
No treatment or management approach is currently established specifically for pathogenic or loss of function variants in the IFNL1 gene. IFNL1 is being studied within the interferon lambda pathway as a possible antiviral treatment target and immune response biomarker, but this does not yet guide routine drug choices.
Gene function
What if the gene works
Your body uses the IFNL1 gene as part of its front line antiviral defense, especially on surfaces exposed to the outside world. It helps cells in the airways, gut, and other lining tissues send a focused signal when viruses are present. This helps explain the IFNL1 gene’s role in antiviral defense at body surfaces.
The IFNL1 gene helps exposed tissues send an early warning when viruses are detected. Its protein acts as a messenger that turns on antiviral genes in nearby cells.
This signal works especially well in cells that line the nose, lungs, gut, and other body surfaces. It helps these tissues strengthen local protection where viruses often first enter.
IFNL1 supports a more targeted response because its message is mainly received by certain surface lining cells. That helps the body fight viruses in a localized way while still coordinating with the wider immune system.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IFNL1 gene can alter how much of its signaling protein is made, how well it folds, and how easily it is released from the cell. Milder changes may slightly reduce signaling, while more disruptive variants can greatly weaken protein stability or its ability to attach to its docking partner on nearby cells. This is one way IFNL1 gene variants affect cell signaling.
How variants are linked to conditions
The IFNL1 gene does not yet have a broadly confirmed link to a specific health condition, although research on IFNL1 gene variants and disease risk is still evolving. Some studies have explored possible associations, but the findings are not established enough to define a clear IFNL1-related condition. Anyone with a diagnosis involving the IFNL1 gene should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead represent natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IFNL1 gene. Any effect of IFNL1 changes may also depend on other genes, infections, and overall health. Anyone with concerns about personal risk should speak with a doctor or genetic counselor.
Inheritance of IFNL1 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for the inheritance of IFNL1 gene variants, and current research does not support labeling them with a single established pattern such as autosomal dominant or autosomal recessive. The IFNL1 gene is located on chromosome 19, which is an autosome. That means each person inherits one copy from each parent, regardless of sex.
What does my IFNL1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for IFNL1. A result in this gene usually does not by itself mean that relatives are likely to have the same health issue or that a clear family risk can be predicted from it alone.
Genetic information
Genetic testing
How you find out about variants
To find variants in the IFNL1 gene, labs use genetic testing on a blood sample, saliva, or cheek swab and read the DNA sequence to look for changes. IFNL1 genetic testing may be done as part of a multigene panel or broader sequencing, and the report classifies any variant by how likely it is to affect health.
When should I consider getting a genetic test?
There is not yet a widely established, IFNL1-specific medical reason for genetic testing. Decisions about testing are usually based on your personal health and family history and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This happens because the body may absorb, break down, transport, or react to a drug a little differently from one person to another. These common differences can influence how well a treatment works or how likely someone is to notice side effects. Medication response is also shaped by age, other health conditions, and other medicines, so genes are one part of the picture.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies gene and drug patterns to better explain why the same treatment may work differently in different people. For many drugs, genes can influence both how powerfully a medicine works and how the body handles it. This understanding can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the IFNL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about how a medicine is working, side effects, or how it fits with your other health conditions, discuss them with your doctor or pharmacist.
History
In 2003, researchers identified the IFNL1 gene during work that uncovered a new branch of the interferon family. Initially understood through its similarity to other immune signaling genes, it was later recognized as part of the type III interferon group. From these first observations, research expanded steadily. Scientists also used the name IL29 in early papers, before the IFNL naming system became more standard. The discovery of the IFNL1 gene helped broaden ideas about how the body’s antiviral signaling network is organized, especially at barrier tissues such as the lungs and gut.